financetom
Business
financetom
/
Business
/
Update: Danaher Shares Rise After Reporting Fiscal Q1 Adjusted Earnings, Sales Decline
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Danaher Shares Rise After Reporting Fiscal Q1 Adjusted Earnings, Sales Decline
Apr 23, 2024 8:42 AM

11:29 AM EDT, 04/23/2024 (MT Newswires) -- (Updates with the latest stock price movement in the headline and first paragraph.)

Danaher's ( DHR ) shares were up more than 7% in recent Tuesday trading after the company reported fiscal Q1 adjusted earnings of $1.92 per diluted share, down from $2.05 a year earlier.

Analysts polled by Capital IQ expected $1.71.

Sales for the quarter ended March 29 were $5.8 billion, down from $5.95 billion a year earlier.

Analysts surveyed by Capital IQ expected $5.62 billion.

The company expects Q2 non-GAAP core revenue to be down mid-single digits and down low-single digits for full-year 2024.

Price: 253.14, Change: +17.06, Percent Change: +7.23

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Day One Biopharmaceuticals to Acquire Mersana Therapeutics
Day One Biopharmaceuticals to Acquire Mersana Therapeutics
Nov 13, 2025
Agreement with Day One Biopharmaceuticals provides for upfront consideration of $25.00 per share in cash, plus potential contingent value rights cash payments of up to an aggregate of $30.25 per share, for aggregate deal value of up to approximately $285 million Closing is expected to occur by the end of January 2026 CAMBRIDGE, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) --...
Tariffs, Inflation Hit DLocal Margins; Stock Plunges
Tariffs, Inflation Hit DLocal Margins; Stock Plunges
Nov 13, 2025
DLocal Limited ( DLO ) shares fell premarket Thursday after the company reported third-quarter fiscal 2025 earnings results. Earnings Results The Uruguayan payments processor reported quarterly earnings of 17 cents per share, beating analyst consensus estimates of 16 cents. Revenue reached $282.48 million, beating the Street estimate of $262.0 million. Revenue surged 52% year over year (Y/Y) and 10% quarter-over-quarter...
Bilibili Q3 Adjusted Earnings, Revenue Rise; Shares Up Pre-Bell
Bilibili Q3 Adjusted Earnings, Revenue Rise; Shares Up Pre-Bell
Nov 13, 2025
05:31 AM EST, 11/13/2025 (MT Newswires) -- Bilibili ( BILI ) reported Q3 adjusted net profit Thursday of 1.75 Chinese renminbi ($0.25) per diluted American depositary share, up from 0.57 renminbi a year earlier. Analysts polled by FactSet expected 1.47 renminbi. Net revenue for the quarter ended Sept. 30 was 7.69 billion renminbi, up from 7.31 billion renminbi a year...
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
Nov 13, 2025
Acquisition expands Day One’s portfolio with novel antibody-drug conjugate (ADC) emiltatug ledadotin (Emi-Le) Emi-Le has demonstrated early anti-tumor activity in an ongoing Phase 1 study for adenoid cystic carcinoma type-1 (ACC-1), a cancer with high unmet need and a lack of therapeutic options Day One will apply existing scientific and commercial capabilities to this investigational innovative therapeutic with a clear...
Copyright 2023-2026 - www.financetom.com All Rights Reserved